Skip to main content
SpringerLink
Log in

Intratumoural injection of autologous lymphocytes plus human lymphoblastoid interferon for the treatment of glioblastoma

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Preliminary experience with a clinical trial of immunotherapy for glioblastoma, by means of intratumoural injection of autologous lymphocytes (AL) mixed with low doses of human lymphoblastoid interferon (HLI) is presented.

In two of twelve patients, a transient reduction of tumoural volume was obtained. Morphological studies showed that injected lymphocytes remain within the tumour, and suggest tumoural lysis due to activity of natural killer (NK) cells.

Clinically no significant prolongation of survival time could be achieved and, as in other series, patients with additional radiation therapy survived longer. But the morphological findings suggest that immunotherapy carrying NK-cells to contact with tumoural cells might be useful in some patients with glioblastoma. Actually no explanation can be given why only two of our cases responded positively. Regarding the otherwise poor prognosis it seems justified to continue these studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barba D, Saris S, Rosenberg SA, Oldenfield EH (1987) Adoptive immunotherapy of malignant gliomas with interleukin-2 autologous lymphokine-activated killer cells. Presented at the Annual Meeting of the American Association of Neurological Surgeons. Dallas, Texas

  2. Bloom WH, Carstairs KC, Crompton MR, McKissock W (1960) Autologous glioma transplantation. Lancet 2: 77–78

    PubMed  Google Scholar 

  3. Brooks WH, Markesbery WR, Gupta D, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4: 219–224

    PubMed  Google Scholar 

  4. Carpen O, Virtanen I, Saksela E (1982) Ultrastructure of human natural killer cells: Nature of the cytolitic contacts in relation to cellular secretion. J Immunol 128: 2691–2697

    PubMed  Google Scholar 

  5. Carpen O, Virtanen I, Lehto VP, Saksela E (1983) Polarization of NK cells cytoskeleton upon conjugation with sensitive target cells. J Immunol 131: 2695–2698

    PubMed  Google Scholar 

  6. Di Lorenzo N, Palma L, Nicole S (1977) Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance. Acta Neurochir (Wien) 39: 27–33

    Google Scholar 

  7. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB (1979) Augmentation of mouse natural killer activity by interferon and interferon inducers. J Immunol 122: 175–181

    PubMed  Google Scholar 

  8. Einhorn S, Blomgren H, Strander H (1978) Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int J Cancer 22: 405–412

    PubMed  Google Scholar 

  9. Herberman RR, Ortaldo JR, Bonnard GD (1979) Augmentation by interferon of human natural and antibody-dependent cellmediated cytotoxicity. Nature 277: 221–223

    PubMed  Google Scholar 

  10. Hook G, Greenwood MA, Chen SN, Barba D, Muul L, Oldfield EH (1987) Interaction of lymphokine-activated killer cells and glioma cells in vitro : Dynamic and ultrastructural morphology. Presented at the Annual Meeting of the American Association of Neurological Surgeons. Dallas, Texas

  11. Ingram M, Shelden CH, Jacques S, Skillen RG, Bradley WG, Techy GB, Freshwater RM, Rand RW (1987) Preliminary clinical trial of immunotherapy for malignant glioma. J Biol Response Mod 6: 489–498

    PubMed  Google Scholar 

  12. Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA (1986) Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report. J Neurosurg 64: 743–749

    PubMed  Google Scholar 

  13. Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA (1986) In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes. J Neurosurg 64: 114–117

    PubMed  Google Scholar 

  14. Kuribayashi K, Gillis S, Kern DE, Henney CS (1981) Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 126: 2321–2327

    PubMed  Google Scholar 

  15. Palma L, Di Lorenzo N, Guidetti B (1978) Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49: 854–861

    PubMed  Google Scholar 

  16. Ridley A, Cavanagh JB (1971) Lymphocytic infiltration in gliomas. Evidence of possible host resistance. Brain 94: 117–124

    PubMed  Google Scholar 

  17. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485–1492

    PubMed  Google Scholar 

  18. Safdari H, Hochberg FH, Richardson EP (1985) Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surg Neurol 23: 221–226

    Google Scholar 

  19. Scheinberg LC, Taylor JM (1968) Immunological aspects of brain tumors. In: Krayenbühl H, Maspes PE, Sweet WH (eds) Progress in neurological surgery, vol 2. Year Book Medical Publishers, Inc, Chicago, pp 267–291

    Google Scholar 

  20. Takakura K, Miki Y, Kubo O, Owaga N, Matsutani M, Sano K (1972) Adjuvant immunotherapy for malignant brain tumors. Jpn J Clin Oncol 12: 109–120

    Google Scholar 

  21. Torten M, Sidell N, Golub SH (1982) Interleukin 2 and stimulator lymphoblastoid cells induce human thymocytes to bind and kill K562 targets. J Exp Med 156: 1545–1550

    PubMed  Google Scholar 

  22. Trinchieri G, Perussia B (1984) Human natural killer cells: Biologic and pathologic aspects. Lab Invest 50: 489–513

    PubMed  Google Scholar 

  23. Trouillas P (1971) Immunologie et immunothérapie des tumeurs cérébrales (à propos de 32 observations). Thèse Doctoral, Lyon

  24. Vaquero J, Martínez R, Barbolla L, De Haro J, De Oya S, Coca S, Ramiro J (1987) Intrathecal injection of autologous leucocytes in glioblastoma: Circulatory dynamics within the subarachnoid space and clinical results. Acta Neurochir (Wien) 89: 37–42

    Google Scholar 

  25. Walker MD, Alexander jr E, Hunt HE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehen EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333–343

    PubMed  Google Scholar 

  26. Young HF, Kaplan A, Regelson W (1977) Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma. A preliminary report. Cancer 40: 1037–1044

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurosurgery and Haematology, Puerta de Hierro Clinic, Autonomous University, Spain

    J. Vaquero, R. Martínez, S. Oya, S. Coca, L. Barbolla, J. Ramiro & F. G. Salazar

  2. Departments of Cellular Biology and Pathology, Complutensis University, Spain

    J. Vaquero, R. Martínez, S. Oya, S. Coca, L. Barbolla, J. Ramiro & F. G. Salazar

  3. Department of Neurosurgery, Gregorio Marañón Hospital, Madrid, Spain

    J. Vaquero, R. Martínez, S. Oya, S. Coca, L. Barbolla, J. Ramiro & F. G. Salazar

Authors
  1. J. Vaquero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Oya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Coca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Barbolla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Ramiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. G. Salazar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaquero, J., Martínez, R., Oya, S. et al. Intratumoural injection of autologous lymphocytes plus human lymphoblastoid interferon for the treatment of glioblastoma. Acta neurochir 98, 35–41 (1989). https://doi.org/10.1007/BF01407174

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01407174

Keywords

Search

Navigation